Skip to content

Clinical trials

Phase 2 Lymphoma, B-Cell, Marginal Zone trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 2 Status: Unknown status Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20051
20072
20081
20092
20111
20141
20161
20171
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Herbert Irving Comprehensive Cancer Center2
National Taiwan University Hospital2
Auxilio Mutuo Cancer Center1
Chinese PLA General Hospital1
Heidelberg University1
Institut Paoli-Calmettes1
Korea Cancer Center Hospital1
Medical College of Wisconsin1
Medical University of Vienna1
Nanjing Sanhome Pharmaceutical, Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone20
Lymphoma, Follicular13
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma9
Lymphoma, Large B-Cell, Diffuse9
Lymphoma, Mantle-Cell9
Lymphoma, Non-Hodgkin9
Burkitt Lymphoma8
Precursor Cell Lymphoblastic Leukemia-Lymphoma8
Lymphoma, Large-Cell, Immunoblastic7

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.